Kenneth Galbraith has joined Ventures West as a venture partner focused on life sciences opportunities. Last year he served as chairman and interim CEO of AnorMED, until its $600 million cash sale to Genzyme. www.ventureswest.com< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: